Instrument Inactif

Autres langues KAINOS Laboratories, Inc.

Actions

4556

JP3205650009

Equipement, fournitures et distribution médicale

Autres langues

22/04	Kainos Laboratories Inc - to retire treasury shares worth 3.6% of outstanding stock on Jun 12
25/03	Denka Company Limited completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. from a group of shareholders.
09/02	Denka Company Limited proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. from a group of shareholders for ¥7.9 billion.
09/02	Denka Unit Launches Tender Offer for Kainos Laboratories
06/02	Denka Co Ltd - Will launch tender offer for Kainos shares
18/12/24	Italian stationery maker FILA cuts stake in listed Indian unit DOMS
14/03/22	KAINOS Laboratories, Inc. announced that it has received ¥250.47 million in funding from Sysmex Corporation
25/02/22	KAINOS Laboratories, Inc. announced that it expects to receive ¥250.47 million in funding from Sysmex Corporation
26/11/21	Tranche Update on KAINOS Laboratories, Inc.'s Equity Buyback Plan announced on November 25, 2021.
26/11/21	KAINOS Laboratories, Inc.'s Equity Buyback announced on November 25, 2021, has closed with 150,000 shares, representing 3.66% for ¥158.1 million.
25/11/21	KAINOS Laboratories, Inc. announces an Equity Buyback for 150,000 shares, for ¥158.1 million.
25/11/21	KAINOS Laboratories, Inc. authorizes a Buyback Plan.
26/11/20	Tranche Update on KAINOS Laboratories, Inc.'s Equity Buyback Plan announced on November 25, 2020.
26/11/20	KAINOS Laboratories, Inc.'s Equity Buyback announced on November 25, 2020, has closed with 88,000 shares, representing 2.02% for ¥90.29 million.
25/11/20	KAINOS Laboratories, Inc. announces an Equity Buyback for 90,000 shares, representing 2.02% for ¥100 million.
25/11/20	KAINOS Laboratories, Inc. authorizes a Buyback Plan.
29/05/19	KAINOS Laboratories, Inc. announced that it has received ¥435.12 million in funding from Asahi Kasei Pharma Corporation
13/05/19	KAINOS Laboratories, Inc. announced that it expects to receive ¥435.12 million in funding from Asahi Kasei Pharma Corporation
26/09/18	Tranche Update on KAINOS Laboratories, Inc.'s Equity Buyback Plan announced on September 25, 2018.
26/09/18	KAINOS Laboratories, Inc.'s Equity Buyback announced on September 25, 2018 has expired with 490,800 shares, representing 11.01% for ¥541.35 million. The company repurchased 490,800 shares from Hitachi Chemical Company, Ltd..
25/09/18	KAINOS Laboratories, Inc. announces an Equity Buyback for 500,000 shares, representing 11.22% for ¥551.5 million.
25/09/18	KAINOS Laboratories, Inc. authorizes a Buyback Plan.
10/02/16	Kainos Laboratories, Inc. announced that it has received ¥105.12 million in funding from Trust & Custody Services Bank, Ltd., Investment Arm.
25/01/16	Kainos Laboratories, Inc. announced that it expects to receive ¥105.12 million in funding from Trust & Custody Services Bank, Ltd., Investment Arm.
26/08/15	Tranche Update on Kainos Laboratories, Inc.'s Equity Buyback Plan announced on August 25, 2015.